The Filings Report

Exelon

EXCNasdaqCIK 1109357Utilities / Utilities - Diversifiedfiscal year ends December70 quarters since 2008

Revenue, Q1 FY2026
$7.2B
+7.9% on Q1 FY2025
Net income
$919M
+1.2% on Q1 FY2025
Free cash flow
−$634M
+15.0% on Q1 FY2025
Diluted EPS
$0.90
0.0% on Q1 FY2025
Revenue, TTM
$24.8B
trailing four quarters
Net margin, TTM
11.2%
net income $2.8B
Free cash flow, TTM
−$2.2B
$6.8B less $8.9B capex
Cash and equivalents
$713M
long-term debt $47.9B, Mar 31, 2026
Shares, 12-month change
+1.4%
1.02B shares, Mar 31, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$1.6B
3.5% of market value
Market value
$47.2B
at the close, buybacks

Latest quarter Q1 FY2026, filed May 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q1 FY2026, the quarter ended March 31, 2026, Exelon reported revenue of $7.2B, +7.9% on Q1 FY2025, and net income of $919M (+1.2%). Operating margin was 22.2%. Free cash flow, operating cash flow less capital expenditures, was −$634M ($1.7B less $2.4B). Diluted earnings per share were $0.90.

The last 16 quarters

Q2 FY2022 to Q1 FY2026, through the filing of May 6, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6B$8BQ2'22, Revenue: $4.2BQ2'22, Net income: $465MQ2'22Q3'22, Revenue: $4.8BQ3'22, Net income: $676MQ3'22Q4'22, Revenue: $4.7BQ4'22, Net income: $432MQ4'22Q1'23, Revenue: $5.6BQ1'23, Net income: $669MQ1'23Q2'23, Revenue: $4.8BQ2'23, Net income: $343MQ2'23Q3'23, Revenue: $6.0BQ3'23, Net income: $700MQ3'23Q4'23, Revenue: $5.4BQ4'23, Net income: $617MQ4'23Q1'24, Revenue: $6.0BQ1'24, Net income: $658MQ1'24Q2'24, Revenue: $5.4BQ2'24, Net income: $448MQ2'24Q3'24, Revenue: $6.2BQ3'24, Net income: $707MQ3'24Q4'24, Revenue: $5.5BQ4'24, Net income: $647MQ4'24Q1'25, Revenue: $6.7BQ1'25, Net income: $908MQ1'25Q2'25, Revenue: $5.4BQ2'25, Net income: $391MQ2'25Q3'25, Revenue: $6.7BQ3'25, Net income: $875MQ3'25Q4'25, Revenue: $5.4BQ4'25, Net income: $594MQ4'25Q1'26, Revenue: $7.2BQ1'26, Net income: $919MQ1'26$0$2B$4B$6B$8BQ2'22, Revenue: $4.2BQ2'22, Net income: $465MQ3'22, Revenue: $4.8BQ3'22, Net income: $676MQ3'22Q4'22, Revenue: $4.7BQ4'22, Net income: $432MQ1'23, Revenue: $5.6BQ1'23, Net income: $669MQ1'23Q2'23, Revenue: $4.8BQ2'23, Net income: $343MQ3'23, Revenue: $6.0BQ3'23, Net income: $700MQ3'23Q4'23, Revenue: $5.4BQ4'23, Net income: $617MQ1'24, Revenue: $6.0BQ1'24, Net income: $658MQ1'24Q2'24, Revenue: $5.4BQ2'24, Net income: $448MQ3'24, Revenue: $6.2BQ3'24, Net income: $707MQ3'24Q4'24, Revenue: $5.5BQ4'24, Net income: $647MQ1'25, Revenue: $6.7BQ1'25, Net income: $908MQ1'25Q2'25, Revenue: $5.4BQ2'25, Net income: $391MQ3'25, Revenue: $6.7BQ3'25, Net income: $875MQ3'25Q4'25, Revenue: $5.4BQ4'25, Net income: $594MQ1'26, Revenue: $7.2BQ1'26, Net income: $919MQ1'26

Net income losses drawn in red.

Free cash flow
−$1.5B−$1.0B−$500M$0$500MQ2'22, Free cash flow: −$127MQ2'22Q3'22, Free cash flow: −$771MQ3'22Q4'22, Free cash flow: −$1.2BQ4'22Q1'23, Free cash flow: −$1.4BQ1'23Q2'23, Free cash flow: −$527MQ2'23Q3'23, Free cash flow: −$324MQ3'23Q4'23, Free cash flow: −$457MQ4'23Q1'24, Free cash flow: −$775MQ1'24Q2'24, Free cash flow: −$237MQ2'24Q3'24, Free cash flow: −$6MQ3'24Q4'24, Free cash flow: −$510MQ4'24Q1'25, Free cash flow: −$746MQ1'25Q2'25, Free cash flow: −$502MQ2'25Q3'25, Free cash flow: $163MQ3'25Q4'25, Free cash flow: −$1.2BQ4'25Q1'26, Free cash flow: −$634MQ1'26−$1.5B−$1.0B−$500M$0$500MQ2'22, Free cash flow: −$127MQ3'22, Free cash flow: −$771MQ3'22Q4'22, Free cash flow: −$1.2BQ1'23, Free cash flow: −$1.4BQ1'23Q2'23, Free cash flow: −$527MQ3'23, Free cash flow: −$324MQ3'23Q4'23, Free cash flow: −$457MQ1'24, Free cash flow: −$775MQ1'24Q2'24, Free cash flow: −$237MQ3'24, Free cash flow: −$6MQ3'24Q4'24, Free cash flow: −$510MQ1'25, Free cash flow: −$746MQ1'25Q2'25, Free cash flow: −$502MQ3'25, Free cash flow: $163MQ3'25Q4'25, Free cash flow: −$1.2BQ1'26, Free cash flow: −$634MQ1'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$20B$40B$60BQ2'22, Cash and equivalents: $816MQ2'22, Long-term debt: $35.8BQ2'22Q3'22, Cash and equivalents: $446MQ3'22, Long-term debt: $35.3BQ3'22Q4'22, Cash and equivalents: $407MQ4'22, Long-term debt: $35.3BQ4'22Q1'23, Cash and equivalents: $522MQ1'23, Long-term debt: $38.7BQ1'23Q2'23, Cash and equivalents: $399MQ2'23, Long-term debt: $39.5BQ2'23Q3'23, Cash and equivalents: $300MQ3'23, Long-term debt: $39.4BQ3'23Q4'23, Cash and equivalents: $445MQ4'23, Long-term debt: $39.7BQ4'23Q1'24, Cash and equivalents: $720MQ1'24, Long-term debt: $42.3BQ1'24Q2'24, Cash and equivalents: $934MQ2'24, Long-term debt: $43.0BQ2'24Q3'24, Cash and equivalents: $616MQ3'24, Long-term debt: $43.7BQ3'24Q4'24, Cash and equivalents: $357MQ4'24, Long-term debt: $42.9BQ4'24Q1'25, Cash and equivalents: $1.0BQ1'25, Long-term debt: $45.3BQ1'25Q2'25, Cash and equivalents: $724MQ2'25, Long-term debt: $45.5BQ2'25Q3'25, Cash and equivalents: $1.5BQ3'25, Long-term debt: $46.3BQ3'25Q4'25, Cash and equivalents: $626MQ4'25, Long-term debt: $47.4BQ4'25Q1'26, Cash and equivalents: $713MQ1'26, Long-term debt: $47.9BQ1'26$0$20B$40B$60BQ2'22, Cash and equivalents: $816MQ2'22, Long-term debt: $35.8BQ3'22, Cash and equivalents: $446MQ3'22, Long-term debt: $35.3BQ3'22Q4'22, Cash and equivalents: $407MQ4'22, Long-term debt: $35.3BQ1'23, Cash and equivalents: $522MQ1'23, Long-term debt: $38.7BQ1'23Q2'23, Cash and equivalents: $399MQ2'23, Long-term debt: $39.5BQ3'23, Cash and equivalents: $300MQ3'23, Long-term debt: $39.4BQ3'23Q4'23, Cash and equivalents: $445MQ4'23, Long-term debt: $39.7BQ1'24, Cash and equivalents: $720MQ1'24, Long-term debt: $42.3BQ1'24Q2'24, Cash and equivalents: $934MQ2'24, Long-term debt: $43.0BQ3'24, Cash and equivalents: $616MQ3'24, Long-term debt: $43.7BQ3'24Q4'24, Cash and equivalents: $357MQ4'24, Long-term debt: $42.9BQ1'25, Cash and equivalents: $1.0BQ1'25, Long-term debt: $45.3BQ1'25Q2'25, Cash and equivalents: $724MQ2'25, Long-term debt: $45.5BQ3'25, Cash and equivalents: $1.5BQ3'25, Long-term debt: $46.3BQ3'25Q4'25, Cash and equivalents: $626MQ4'25, Long-term debt: $47.4BQ1'26, Cash and equivalents: $713MQ1'26, Long-term debt: $47.9BQ1'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q1 FY2026 filed May 6, 2026.

Exelon income statement, quarterly
Millions of dollarsQ1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 30, 2025filed Nov 4, 2025Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 12, 2025Q3 FY2024ended Sep 30, 2024filed Oct 30, 2024Q2 FY2024ended Jun 30, 2024filed Aug 1, 2024YoYQ1 FY2026vs Q1 FY2025
Revenue7,2425,4126,7055,4276,7145,4716,1545,361+7.9%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative—————————
Operating income1,6051,1851,5009271,5361,0981,196913+4.5%
Other income (expense)(486)(464)(470)(466)(458)(402)(439)(419)−6.1%
Pretax income1,1197211,0304611,078696757494+3.8%
Income tax20012715570170495046+17.6%
Net income919594875391908647707448+1.2%
Diluted EPS ($)0.90—0.860.390.90—0.700.450.0%
Diluted shares (millions)1,026—1,0131,0121,009—1,0041,001—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q1 FY2026 filed May 6, 2026.

Exelon balance sheet, quarterly
Millions of dollarsQ1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 30, 2025filed Nov 4, 2025Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 12, 2025Q3 FY2024ended Sep 30, 2024filed Oct 30, 2024Q2 FY2024ended Jun 30, 2024filed Aug 1, 2024YoYQ1 FY2026vs Q1 FY2025
Cash and equivalents7136261,5337241,004357616934−29.0%
Short-term investments—————————
Total current assets9,0029,5469,2298,6768,7998,3848,0238,557+2.3%
Total assets117,545116,570113,539111,147109,484107,784106,070105,113+7.4%
Total current liabilities9,58810,3319,8259,1568,1039,6117,3848,275+18.3%
Long-term debt47,85947,41346,28345,52745,34242,94743,70143,039+5.6%
Total liabilities88,23087,77285,42683,52781,87780,86379,44878,961+7.8%
Stockholders’ equity29,31528,79828,11327,62027,60726,92126,62226,152+6.2%
Shares outstanding (millions)1,0231,0231,0101,0101,0101,0051,0051,000—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q1 FY2026 filed May 6, 2026.

Exelon cash flow statement, quarterly
Millions of dollarsQ1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 30, 2025filed Nov 4, 2025Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 12, 2025Q3 FY2024ended Sep 30, 2024filed Oct 30, 2024Q2 FY2024ended Jun 30, 2024filed Aug 1, 2024YoYQ1 FY2026vs Q1 FY2025
Operating cash flow1,7241,2442,2991,5111,2001,4261,6891,462+43.7%
Capital expenditures2,3582,4342,1362,0131,9461,9361,6951,699+21.2%
Free cash flow (CFO − capex)(634)(1,190)163(502)(746)(510)(6)(237)+15.0%
Depreciation and amortization953924913901905913909894+5.3%
Share repurchases—————————
Dividends paid430405404405403382381380+6.7%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 12, 2026.

Income statement

Exelon income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 21, 2024FY2022ended Dec 31, 2022filed Feb 14, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 11, 2020FY2018ended Dec 31, 2018filed Feb 8, 2019FY2017ended Dec 31, 2017filed Feb 9, 2018FY2016ended Dec 31, 2016filed Feb 13, 2017FY2015ended Dec 31, 2015filed Feb 10, 2016FY2014ended Dec 31, 2014filed Feb 13, 2015FY2013ended Dec 31, 2013filed Feb 14, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Apr 23, 2010FY2008ended Dec 31, 2008filed Jul 24, 2009
Revenue24,25823,02821,72719,07817,93816,66334,43835,97833,55831,36629,44727,42924,88823,48919,06318,64417,31818,859
Cost of revenue——————————————————
Gross profit——————————————————
Research and development——————————————————
Selling, general and administrative——————————————————
Operating income5,1484,3194,0233,3152,6822,1914,3743,8914,3883,2124,4093,0963,6692,3734,4794,7264,7505,299
Other income (expense)(1,857)(1,652)(1,321)(912)(1,028)(1,099)(389)(1,666)(613)(1,239)(1,079)(610)(896)(575)(523)(505)(331)(1,265)
Pretax income3,2912,6672,7022,4031,6541,0923,9852,2253,7751,9733,3302,4862,7731,7983,9564,2214,419—
Income tax52320737434938(7)774118(126)7531,0736661,0446271,4571,6581,7121,317
Net income2,7682,4602,3282,1701,7061,9632,9362,0053,7791,1212,2691,6231,7191,1602,4952,563——
Diluted EPS ($)————1.742.013.012.073.981.212.541.882.001.423.753.874.094.13
Diluted shares (millions)1,0121,003997987980977974969949927893864860819665663662662

Balance sheet

Exelon balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 21, 2024FY2022ended Dec 31, 2022filed Feb 14, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 11, 2020FY2018ended Dec 31, 2018filed Feb 8, 2019FY2017ended Dec 31, 2017filed Feb 9, 2018FY2016ended Dec 31, 2016filed Feb 13, 2017FY2015ended Dec 31, 2015filed Feb 10, 2016FY2014ended Dec 31, 2014filed Feb 13, 2015FY2013ended Dec 31, 2013filed Feb 14, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Apr 23, 2010FY2008ended Dec 31, 2008filed Jul 24, 2009
Cash and equivalents6263574454076724325871,3498986356,5021,8781,6091,4861,0161,6122,0101,271
Short-term investments——————————————————
Total current assets9,5468,3848,0877,33613,95712,56212,03713,32811,89612,41215,33411,85310,13710,1405,7136,3985,4415,368
Total assets116,570107,784101,85695,349133,013129,317124,977119,634116,770114,90495,38486,41679,92478,56154,99552,24049,18047,817
Total current liabilities10,3319,6119,90110,61116,11112,77114,18511,40410,79813,4579,1188,7627,7287,7915,1344,2404,2384,080
Long-term debt47,41342,94739,69235,27230,74935,09331,32934,07532,17631,57523,64519,21217,62317,19011,79911,61410,99511,397
Total liabilities87,77280,86376,10170,60598,21894,44990,40486,58784,58387,29268,06262,28356,98456,74440,52038,59036,45336,683
Stockholders’ equity28,79826,92125,75524,74434,39332,58532,22430,74129,89625,83725,79322,60822,73221,43114,38513,56012,64011,047
Shares outstanding (millions)1,0231,0051,000994980976974970965927920860857663663659660—

Cash flow statement

Exelon cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 12, 2025FY2023ended Dec 31, 2023filed Feb 21, 2024FY2022ended Dec 31, 2022filed Feb 14, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 11, 2020FY2018ended Dec 31, 2018filed Feb 8, 2019FY2017ended Dec 31, 2017filed Feb 9, 2018FY2016ended Dec 31, 2016filed Feb 13, 2017FY2015ended Dec 31, 2015filed Feb 10, 2016FY2014ended Dec 31, 2014filed Feb 13, 2015FY2013ended Dec 31, 2013filed Feb 14, 2014FY2012ended Dec 31, 2012filed Feb 22, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Apr 23, 2010FY2008ended Dec 31, 2008filed Jul 24, 2009
Operating cash flow6,2545,5694,7034,8703,0124,2356,6598,6447,4808,4617,6164,4576,3436,1314,8535,2446,0946,551
Capital expenditures8,5297,0977,4087,1477,9818,0487,2487,5947,5848,5537,6246,0775,3955,7894,0423,3263,2733,117
Free cash flow (CFO − capex)(2,275)(1,528)(2,705)(2,277)(4,969)(3,813)(589)1,050(104)(92)(8)(1,620)9483428111,9182,8213,434
Depreciation and amortization3,6433,5963,5063,5337,5732,8914,2524,3533,8283,9362,4502,3142,1531,8811,3472,0751,8342,308
Share repurchases—————————————0000436
Dividends paid1,6171,5241,4331,3341,4971,4921,4081,3321,2361,1661,1051,0651,2491,7161,3931,3891,3851,335

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$0
0 sales by 0 insiders; officers and directors $0

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Mar 31, 2026Segedi Bryan KDirectorawardindirect878$49.82$44K9,451Apr 1, 2026
Mar 31, 2026Rogers Matthew CDirectorawardindirect878$49.82$44K12,554Apr 1, 2026
Mar 31, 2026Richo AnnaDirectorawardindirect878$49.82$44K11,337Apr 1, 2026
Mar 31, 2026Lillie Charisse RDirectorawardindirect878$49.82$44K12,554Apr 1, 2026
Mar 31, 2026Jojo Linda PDirectorawardindirect878$49.82$44K56,036Apr 1, 2026
Mar 31, 2026Dewalt David GDirectorawardindirect878$49.82$44K4,009Apr 1, 2026
Mar 31, 2026Cheshire Marjorie RodgersDirectorawardindirect878$49.82$44K25,723Apr 1, 2026
Mar 31, 2026Bowers William PDirectorawardindirect878$49.82$44K19,978Apr 1, 2026
Feb 2, 2026Kleczynski Robert ASVP, Controller & Taxoption exercise1,684——44,283Feb 4, 2026
Feb 2, 2026Kleczynski Robert ASVP, Controller & Taxoption exercise7,019——53,412Feb 4, 2026
Feb 2, 2026Kleczynski Robert ASVP, Controller & Taxoption exercise2,110——46,393Feb 4, 2026
Feb 2, 2026Kleczynski Robert ASVP, Controller & Taxdisposition to issuer4,963$43.91$218K44,681Feb 4, 2026
Feb 2, 2026Kleczynski Robert ASVP, Controller & Taxoption exercise1,474——42,599Feb 4, 2026
Feb 2, 2026Kleczynski Robert ASVP, Controller & Taxtax withholding3,768$43.91$165K49,644Feb 4, 2026
Feb 2, 2026Jones Jeanne MEVP, CFO, Audit & Riskoption exercise7,031——59,306Feb 4, 2026
Feb 2, 2026Jones Jeanne MEVP, CFO, Audit & Riskoption exercise24,701——84,007Feb 4, 2026
Feb 2, 2026Jones Jeanne MEVP, CFO, Audit & Risktax withholding16,051$43.91$705K67,956Feb 4, 2026
Feb 2, 2026Jones Jeanne MEVP, CFO, Audit & Riskoption exercise5,197——45,790Feb 4, 2026
Feb 2, 2026Jones Jeanne MEVP, CFO, Audit & Riskoption exercise6,485——52,275Feb 4, 2026
Feb 2, 2026Jones Jeanne MEVP, CFO, Audit & Riskdisposition to issuer7,154$43.91$314K60,802Feb 4, 2026
Feb 2, 2026Innocenzo MichaelEVP & Chief Operating Officerdisposition to issuer7,199$43.91$316K86,802Feb 4, 2026
Feb 2, 2026Innocenzo MichaelEVP & Chief Operating Officertax withholding9,547$43.91$419K94,001Feb 4, 2026
Feb 2, 2026Innocenzo MichaelEVP & Chief Operating Officeroption exercise7,734——91,993Feb 4, 2026
Feb 2, 2026Innocenzo MichaelEVP & Chief Operating Officeroption exercise5,748——84,259Feb 4, 2026
Feb 2, 2026Innocenzo MichaelEVP & Chief Operating Officeroption exercise2,432——78,511Feb 4, 2026

Full insider history for Exelon, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
EXELON CORPORATION, CIK 1109357 on EDGAR
Extract generated
August 28, 2026
Withheld
2 line-years whose four quarters do not sum to the filed year: depreciation amortization FY2009, depreciation amortization FY2021
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2018, income tax FY2021
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: not filed
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAmortizationAndAccretionNet, DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated August 28, 2026.

JSON file
/data/financials/EXC.json